Home

Insights

Medicamen Biotech Ltd P/E Ratio

Medicamen Biotech Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.9 K

stocks traded

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

PE

54.4

Last updated : 19 May 01:15 AM

Key Highlights

    The P/E Ratio of Medicamen Biotech Ltd is 54.4 as of 19 May 01:15 AM .a1#The P/E Ratio of Medicamen Biotech Ltd changed from 47.2 on March 2019 to 55.9 on March 2023 . This represents a CAGR of 3.44% over 5 years. a1#The Latest Trading Price of Medicamen Biotech Ltd is ₹ 536.95 as of 18 May 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Medicamen Biotech Ltd changed from ₹ 567.33 crore on March 2019 to ₹ 829.34 crore on March 2023 . This represents a CAGR of 7.89% over 5 years. a1#The Revenue of Medicamen Biotech Ltd changed from ₹ 34.05 crore to ₹ 47.33 crore over 7 quarters. This represents a CAGR of 20.71% a1#The EBITDA of Medicamen Biotech Ltd changed from ₹ 6.62 crore to ₹ 5.72 crore over 7 quarters. This represents a CAGR of -8.01% a1#The Net Profit of Medicamen Biotech Ltd changed from ₹ 3.59 crore to ₹ 2.03 crore over 7 quarters. This represents a CAGR of -27.80% a1#The Dividend Payout of Medicamen Biotech Ltd changed from 9.73 % on March 2019 to 8.43 % on March 2023 . This represents a CAGR of -2.83% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1947.2
Mar '2016.6
Mar '2153.8
Mar '2252.8
Mar '2355.9

Fundamental Metrics

Market Cap

679 Cr

EPS

9.2

P/E Ratio (TTM) *

54.4

P/B Ratio (TTM) *

3.2

Day’s High

556.95

Day’s Low

530.0

DTE *

0.1

ROE *

6.7

52 Week High

903.5

52 Week Low

356.75

ROCE *

8.4

* All values are consolidated

* All values are consolidated

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

PRICE

536.95

6.50(1.23%)

stock direction

Last updated : 18 May 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Medicamen Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

Asset Value vs Market Value

Market Value

632

Asset Value

165

2.8 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

11 Cr

54.4 X

PE Ratio

Market Cap

₹631.99Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

11 Cr

54.4 X

PE Ratio

Market Cap

₹631.99Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Medicamen Biotech Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Medicamen Biotech Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Medicamen Biotech Ltd's Share Price stands at 536.95. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-18T00:00:00 is 9.18. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 536.95/ 9.18= 54.42.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Medicamen Biotech Ltd's stock is trading at approximately 54.42 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Medicamen Biotech Ltd’s PE Ratio (BSE: MEDICAMEQ)

    The Price-to-Earnings (PE) ratio, used to assess Medicamen Biotech Ltd's stock (BSE: MEDICAMEQ), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '19567
Mar '20221
Mar '21652
Mar '22786
Mar '23829

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '2234
Sep '2234
Dec '2236
Mar '2239
Jun '2342
Sep '2344
Dec '2347

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '227
Sep '226
Dec '227
Mar '227
Jun '237
Sep '235
Dec '236

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '224
Sep '224
Dec '224
Mar '224
Jun '234
Sep '231
Dec '232

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1910
Mar '205
Mar '2110
Mar '228
Mar '238

* All values are a in %

About Medicamen Biotech Ltd

About Medicamen Biotech Ltd

    Medicamen Biotech Ltd is a widely held, Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries. During the year 2006-07, the company added Analgesic and Anti bacterial, Anti filarial and Anti TB products in its range and done two mega projects of Govt. The Company launched the marketing division in Jan'09, with 16 products in Delhi & Uttrakhand regions.

Medicamen Biotech Ltd News Hub

News

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 12 Febru...

Read more

06 Feb 2024 14:01

News

Medicamen Biotech to convene board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 10 Novem...

Read more

06 Nov 2023 11:18

News

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the 30th Annual General Meeting (AGM) of the company will...

Read more

10 Aug 2023 13:59

News

Medicamen Biotech to discuss results

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 8 August...

Read more

02 Aug 2023 17:29

News

Board of Medicamen Biotech recommends final dividend

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held...

Read more

02 Jun 2023 18:44

News

Medicamen Biotech to announce Quarterly Result

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2...

Read more

27 May 2023 16:51

Product Composition by Percentage (Revenue)

FAQs for PE of Medicamen Biotech Ltd

What is Medicamen Biotech Ltd current share price?

The current market price of Medicamen Biotech Ltd as of May 19, 2024 is ₹536.95.

What is Medicamen Biotech Ltd's market cap?

Medicamen Biotech Ltd's market capitalisation stood at ₹631 Cr as of May 19, 2024

What are Medicamen Biotech Ltd's total net assets?

According to Medicamen Biotech Ltd's most recent financial filings, the company's net assets total ₹165.2 Cr.

Is Medicamen Biotech Ltd making a profit or loss?

Medicamen Biotech Ltd's net Profit as of May 19, 2024 is close to ₹11 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199